AV Junction Ablation or Optimal Medical Treatment in PatiEnts With Cardiac Resynchronization Therapy and Permanent Atrial Fibrillation

Recruiting now · Not applicable

Conditions studied: Recurrent Atrial Fibrillation, Persistent Atrial Fibrillation

In brief

A study comparing atrioventricular junction ablation (AVJA) versus continued optimum medical rate control in patients with cardiac resynchronization therapy (CRT) and atrial fibrillation (AF) with suboptimal heart rate control on optimum medication.

Key facts

Study ID
NCT05776797
Run by
University Hospital Ostrava
People needed
480
Starts
2023-04-01
Expected to finish
2029-03-31
Last updated by the study team
2023-06-08

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.